KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal ...
NOOSAVILLE, Australia--(BUSINESS WIRE)--Provectus Algae (Provectus), an Australian synthetic biology company specializing in microalgal biomanufacturing technologies for the production of specialty ...
Thank you for your continued support of Provectus in 2022. As fellow, longtime shareholders, our leadership team is committed to maximizing the long-term, fundamental value of the Company through the ...
KNOXVILLE, TN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from the Company’s ongoing, multi-cohort, Phase 1b/2 study of the combination therapy of cancer ...
Names Ed Pershing as Chief Executive Officer and Dominic Rodrigues as President Mr. Pershing stated, “Since 2017, Mr. Rodrigues has managed clinical development, research collaborations, key vendors, ...
Provectus Algae (Provectus) has announced that Steven F. Schnittger has joined the company as a cosmetics industry advisor. Schnittger is the former Vice-President of Global Fermentation and ...
Federal investigators accuse two former Provectus Biopharmaceuticals Inc. executives of defrauding investors of millions. A lawsuit filed Dec. 12 in Knoxville’s U.S. District Court accuses Provectus ...
Provectus Algae programs algae to create category-defining bioproducts and sustainable industrial solutions. Through its proprietary Precision Photosynthesis® and artificial intelligence (AI) enabled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results